treatment group – Page 7 – Communicable Diseases Research

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab

Poster Abstracts

Published on 2021-11-042022-10-29
Journal: Open Forum Infectious Diseases [Category] COVID-19,

The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study

코로나19가 오말리주맙과 항히스타민제로 치료받은 만성 자발성 두드러기 환자에 미치는 영향: 단면, 비교 연구

Comparative Study

Published on 2021-11-012022-09-12
Journal: Journal of cosmetic dermatology [Category] MERS, 진단,

Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial

Randomized Controlled Trial

Published on 2021-11-012022-10-05
Journal: Phytotherapy research : PTR [Category] SARS, 임상,

[키워드] accelerated anorexia chills clinical experience Clinical improvement conducted Controlled clinical trial coronavirus cough COVID-19 demonstrated dry cough Dyspnea Effect Endpoint fatigue FIVE headache herbal medicine hospital Hospital stay Hospitalized Iran microbial infection multicenter Multicenter trial Open-label Pain pandemic Patient patients patients with COVID-19 Persian medicine phytotherapy questionnaire Randomized respiratory diseases Result routine care secondary outcome Significant significantly sputum standard care Symptom symptoms of COVID-19 Tehran Tolerability Treatment treatment group vertigo
[DOI] 10.1002/ptr.7277 PMC 바로가기 [Article Type] Randomized Controlled Trial

ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation

Article

Published on 2021-10-312022-10-28
Journal: Archives of pharmacology and therapeutics [Category] COVID-19,

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19

Clinical Trial

Published on 2021-10-202022-10-04
Journal: Frontiers in Immunology [Category] SARS, 임상,

[키워드] 95% CI ARDS BALF Bronchoalveolar lavage fluid cleaving clinical clinical trial complexes COVID - 19 COVID-19 Degradation develop DNA Dornase alfa Effect Effects evaluate the effect Extracellular extracellular DNA fraction Genentech improvement Inhaled inhibited Lung compliance MPO NET NETs Neutrophil extracellular trap non-randomized oxygen oxygen saturation Oxygenation P-value PaO Patient patients with ARDS performed pilot study Pneumonia positive reduction in Registration respiratory Respiratory failure Result secondary to Severe case Structure sustained therapy treatment group Viral
[DOI] 10.3389/fimmu.2021.714833 PMC 바로가기 [Article Type] Clinical Trial

Progress feedback in children and adolescents with internalizing and externalizing symptoms in routine care (OPTIE study): study protocol of a randomized parallel-group trial

Study Protocol

Published on 2021-10-152022-10-27
Journal: BMC Psychiatry [Category] Coronavirus, MERS, SARS,

[키워드] applied assigned baseline Behavior therapy blinded children Children and adolescents clinical clinician collected component condition conducted contribute Effect Efficacy Evidence Externalizing feature Feedback-informed treatment FIVE include Inclusion Internalizing Intervention investigated manuscript medium parallel-group participant Patient Progress Progress feedback provide Randomized Randomized controlled trial randomized trial receive routine care Routine outcome monitoring Sample size stratified block randomization Study protocol Symptom Symptoms the patient therapeutic alliance therapy Treatment treatment group treatment groups Trial trial protocol university hospital while
[DOI] 10.1186/s12888-021-03502-w PMC 바로가기 [Article Type] Study Protocol

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

Medicine

Published on 2021-10-152022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] Anticoagulant anticoagulation cohort of patient COVID-19 COVID-19 patient death evaluate the effect exclusion French Hospitalization Hospitalized In-hospital in-hospital mortality intermediate intermediate dose intermediate-dose group Kaplan–Meier LMWH Microthrombosis Mortality observé occurred Patient patients with COVID-19 Primary outcome Prophylactic prophylactic treatment reduction in regimen Retrospective study SARS-CoV-2 significant difference Standard dose Standard-dose statistically significant difference thrombosis thrombotic thrombotic event treated Treatment treatment group Trigger venous worsening
[DOI] 10.3389/fmed.2021.747527 PMC 바로가기 [Article Type] Medicine

Progress feedback in children and adolescents with internalizing and externalizing symptoms in routine care (OPTIE study): study protocol of a randomized parallel-group trial

일상적인 치료에서 내재화 및 외부화 증상을 가진 어린이 및 청소년의 진보 피드백 (Optie Study) : 무작위 병렬 그룹 시험의 연구 프로토콜

Study Protocol

Published on 2021-10-152022-09-10
Journal: BMC Psychiatry [Category] 임상,

[키워드] applied assigned baseline Behavior therapy behavioral therapy blinded Caregiver Child children Children and adolescents clinical clinician collected component condition conducted contribute Effect Efficacy Evidence Externalizing feature feedback Feedback-informed treatment FIVE include Inclusion Internalizing Intervention investigated manuscript medium motivation parallel-group participant Patient Progress Progress feedback provide Randomized Randomized controlled trial randomized trial receive routine care Routine outcome monitoring Sample size stratified block randomization Study protocol Symptom Symptoms teacher the patient therapeutic alliance therapist therapy Treatment treatment group treatment groups Trial trial protocol university hospital while
[DOI] 10.1186/s12888-021-03502-w PMC 바로가기 [Article Type] Study Protocol

Impact of the TEAM Wheels eHealth manual wheelchair training program: Study protocol for a randomized controlled trial

Study Protocol

Published on 2021-10-132022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial

Randomized Controlled Trial

Published on 2021-10-012022-10-05
Journal: Biological trace element research [Category] SARS, 임상,

[키워드] age age and gender antioxidants baseline Chloroquine chloroquine/hydroxychloroquine clinical Clinical efficacy Clinical severity conducted COVID COVID 19 COVID-19 infection COVID-19 patients death diagnosis of COVID-19 effective ENhance evaluate evaluate the effect group had no HCQ hospital Infection laboratory parameter mechanical ventilation morbidity and mortality Mortality overall mortality pandemic Patient primary endpoint Randomized randomized clinical trial randomized study reduce regression analysis risk factor significant difference specific treatment the patient therapy Treatment treatment group two group university Zinc
[DOI] 10.1007/s12011-020-02512-1 PMC 바로가기 [Article Type] Randomized Controlled Trial